Clinical, Enzymatic, and Molecular Characterisation of a Portuguese Family With a Chronic Form of GM2-gangliosidosis B1 Variant.

Journal of Medical Genetics - United Kingdom
doi 10.1136/jmg.33.4.341
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

BMJ

Related search

Biochemical Characterization of the GM2 Gangliosidosis B1 Variant

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2004English

GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2015English

Deficiency of the Hexosaminidase a Activator Protein in a Case of GM2 Gangliosidosis; Variant AB

Pediatric Research
Child HealthPediatricsPerinatology
1982English

Different Attenuated Phenotypes of GM2 Gangliosidosis Variant B in Japanese Patients With HEXA Mutations at Codon 499, and Five Novel Mutations Responsible for Infantile Acute Form

Journal of Human Genetics
Genetics
2003English

Partial Deficiency of Beta-Hexosaminidase Activity in Canine GM2-gangliosidosis.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1987English

377. Significant Therapeutic Benefit After Post-Symptomatic Gene Therapy in a Feline Model of GM2 Gangliosidosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Eosinophilic Esophagitis in Portuguese Children: Clinical and Allergological Characterisation

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

711. Intravenous Neonatal Gene Therapy Corrects GM2 Gangliosidosis in Sandhoff Mice for Long-Term, by Using AAV Viral Vector Expressing a New Hexosaminidase Variant

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

High-Throughput PRPF31 Variant Characterisation Pipeline Consistent With ACMG/AMP Clinical Variant Interpretation Guidelines

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy